
Entera Bio Ltd.
ENTXHealthcare|Biotechnology|IL
$3.14
+0.15 (+5.02%)
DCF Value
$0.14
Tangible Book / Share
$1.89
Graham Number
$0.72
Cash / Share
$1.83
Ownership Breakdown
67.7%
Float
173.9M
Shares Outstanding
117.8M
Float Shares
Major Holders (40)
Combined: 210.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | Other | 15.00% | 5,881,879 | Nov 20, 2024 | 13D/G |
| Gakasa Holdings, LLC | Other | 15.00% | 5,881,879 | Nov 20, 2024 | 13D/G |
| Lampert Mark N | Individual | 9.99% | 17,225,121 | Aug 4, 2026 | 13D/G |
| BVF Inc/Il | Corporation | 9.99% | 17,225,121 | Aug 4, 2026 | 13D/G |
| BVF Partners L P/Il | IA, PN | 9.99% | 17,225,121 | Aug 4, 2026 | 13D/G |
| BVF GP Holdings LLC | Other | 9.20% | 15,857,221 | Aug 4, 2026 | 13D/G |
| Opko Health, Inc. | Corporation | 8.10% | 3,685,226 | Apr 2, 2025 | 13D/G |
| TCG Crossover GP III, LLC | Other | 7.10% | 12,254,901 | Aug 4, 2026 | 13D/G |
| Chen Yu | Individual | 7.10% | 12,254,901 | Aug 4, 2026 | 13D/G |
| TCG Crossover Fund III, L.P. | Partnership | 7.10% | 12,254,901 | Aug 4, 2026 | 13D/G |
| Vivo Opportunity, LLC | Other | 6.90% | 11,817,401 | Aug 4, 2026 | 13D/G |
| BVF I GP LLC | Other | 5.30% | 9,171,741 | Aug 4, 2026 | 13D/G |
| Biotechnology Value Fund L P | Partnership | 5.30% | 9,171,741 | Aug 4, 2026 | 13D/G |
| Venrock Healthcare Capital Partners III, L.P. | Partnership | 5.10% | 8,861,763 | Oct 30, 2026 | 13D/G |
| VHCP Management EG, LLC | Other | 5.10% | 8,861,763 | Oct 30, 2026 | 13D/G |
| Bong Y. Koh | Individual | 5.10% | 8,861,763 | Oct 30, 2026 | 13D/G |
| Nimish Shah | Individual | 5.10% | 8,861,763 | Oct 30, 2026 | 13D/G |
| VHCP Management III, LLC | Other | 5.10% | 8,861,763 | Oct 30, 2026 | 13D/G |
| Venrock Healthcare Capital Partners EG, L.P. | Partnership | 5.10% | 8,861,763 | Oct 30, 2026 | 13D/G |
| VHCP Co-Investment Holdings III, LLC | Other | 5.10% | 8,861,763 | Oct 30, 2026 | 13D/G |
| Longitude Venture Partners V, L.P. | Partnership | 4.60% | 7,843,138 | Aug 4, 2026 | 13D/G |
| Patrick G. Enright | Individual | 4.60% | 7,843,138 | Aug 4, 2026 | 13D/G |
| Juliet Tammenoms Bakker | Individual | 4.60% | 7,843,138 | Aug 4, 2026 | 13D/G |
| Longitude Capital Partners V, LLC | Other | 4.60% | 7,843,138 | Aug 4, 2026 | 13D/G |
| Seven Fleet Capital Management GP LLC | Other | 4.10% | 7,053,898 | Aug 4, 2026 | 13D/G |
| Brian Liu | Individual | 4.10% | 7,053,898 | Aug 4, 2026 | 13D/G |
| Seven Fleet Capital Management LP | Other | 4.10% | 7,053,898 | Aug 4, 2026 | 13D/G |
| BVF II GP LLC | Other | 3.90% | 6,685,480 | Aug 4, 2026 | 13D/G |
| Biotechnology Value Fund II LP | Partnership | 3.90% | 6,685,480 | Aug 4, 2026 | 13D/G |
| Seven Fleet Master Fund LP | Partnership | 3.00% | 5,093,114 | Aug 4, 2026 | 13D/G |
| Vivo Opportunity Co-Invest (Cycle 3), L.P. | Partnership | 2.80% | 4,768,382 | Aug 4, 2026 | 13D/G |
| Steven A. Cohen | Individual | 2.60% | 1,183,116 | Nov 14, 2025 | 13D/G |
| Point72 Capital Advisors, Inc. | Corporation | 2.60% | 1,183,116 | Nov 14, 2025 | 13D/G |
| Point72 Asset Management, L.P. | Partnership | 2.60% | 1,183,116 | Nov 14, 2025 | 13D/G |
| Vivo Opportunity Fund Holdings, L.P. | Partnership | 2.50% | 4,330,882 | Aug 4, 2026 | 13D/G |
| Vivo Opportunity Co-Invest, L.P. | Partnership | 1.60% | 2,718,137 | Aug 4, 2026 | 13D/G |
| Seven Fleet Horizon Master Fund LP | Partnership | 1.10% | 1,960,784 | Aug 4, 2026 | 13D/G |
| BVF Partners OS Ltd. | Corporation | 0.70% | 1,124,329 | Aug 4, 2026 | 13D/G |
| Biotechnology Value Trading Fund OS LP | Partnership | 0.70% | 1,124,329 | Aug 4, 2026 | 13D/G |
| Vivo Opportunity Cayman, LLC | Other | 0.30% | 437,500 | Aug 4, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 2,484,102 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Camisasca Riccardo Paolo | officer | Aug 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Malca Yonatan | director | Aug 7, 2026 | AWARD | 22,815 | — | — | Form 4 |
| Taitel Haya | director | Aug 7, 2026 | AWARD | 20,790 | — | — | Form 4 |
| Ellis Sean | director | Aug 7, 2026 | AWARD | 20,034 | — | — | Form 4 |
| Ellis Sean | director | Aug 7, 2026 | AWARD | 40,000 | $1.37 | $54.8K | Form 4 |
| Yaacov-Garbeli Dana | Chief Financial Officer | Aug 7, 2026 | AWARD | 140,000 | $1.37 | $191.8K | Form 4 |
| Galitzer Hillel | Chief Operating Officer | Aug 7, 2026 | AWARD | 200,000 | $1.37 | $274.0K | Form 4 |
| Burshtein Gregory | Chief of R&D | Aug 7, 2026 | AWARD | 180,000 | $1.37 | $246.6K | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Aug 7, 2026 | AWARD | 500,000 | $1.37 | $685.0K | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Aug 7, 2026 | AWARD | 200,000 | $2.81 | $562.0K | Form 4 |
| Germano Geno J | director | Aug 7, 2026 | AWARD | 25,014 | — | — | Form 4 |
| Germano Geno J | director | Aug 7, 2026 | AWARD | 50,000 | $1.37 | $68.5K | Form 4 |
| Germano Geno J | director | Aug 7, 2026 | AWARD | 43,014 | $1.37 | $58.9K | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Jul 14, 2026 | AWARD | 72,993 | — | — | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Jul 14, 2026 | AWARD | 347,567 | — | — | Form 4 |
| Galitzer Hillel | Chief Operating Officer | May 7, 2026 | AWARD | 72,993 | — | — | Form 4 |
| Yaacov-Garbeli Dana | Chief Financial Officer | May 7, 2026 | AWARD | 58,394 | — | — | Form 4 |
| Burshtein Gregory | Chief of R&D | May 7, 2026 | AWARD | 87,591 | — | — | Form 4 |
| Germano Geno J | director | Mar 9, 2026 | BUY | 20,000 | $1.30 | $26.0K | Form 4 |
| Ellis Sean | director | Mar 5, 2026 | BUY | 10,000 | $1.23 | $12.3K | Form 4 |
| Taitel Haya | director | Feb 10, 2026 | BUY | 7,500 | $1.48 | $11.1K | Form 4 |
| Germano Geno J | director | Feb 10, 2026 | BUY | 20,000 | $1.49 | $29.8K | Form 4 |
| Ellis Sean | director | Feb 9, 2026 | BUY | 18,000 | $1.24 | $22.3K | Form 4 |
| Germano Geno J | director: | Feb 4, 2026 | OTHER | 0 | — | — | Form 4 |
| OSTROV GERALD M | director | Jan 1, 2026 | AWARD | 28,721 | — | — | Form 4 |
| OSTROV GERALD M | director | Jan 1, 2026 | AWARD | 33,505 | $1.94 | $65.0K | Form 4 |
| Ellis Sean | director | Jan 1, 2026 | AWARD | 25,371 | — | — | Form 4 |
| Ellis Sean | director | Jan 1, 2026 | AWARD | 33,505 | $1.94 | $65.0K | Form 4 |
| Malca Yonatan | director | Jan 1, 2026 | AWARD | 30,157 | — | — | Form 4 |
| Malca Yonatan | director | Jan 1, 2026 | AWARD | 33,505 | $1.94 | $65.0K | Form 4 |
| LIEBERMAN GERALD M | director | Jan 1, 2026 | AWARD | 38,294 | — | — | Form 4 |
| LIEBERMAN GERALD M | director | Jan 1, 2026 | AWARD | 33,505 | $1.94 | $65.0K | Form 4 |
| Taitel Haya | director | Jan 1, 2026 | AWARD | 26,329 | — | — | Form 4 |
| Taitel Haya | director | Jan 1, 2026 | AWARD | 33,505 | $1.94 | $65.0K | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Dec 29, 2025 | BUY | 11,000 | $1.81 | $19.9K | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Jul 16, 2025 | AWARD | 500,000 | $2.28 | $1.1M | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Jul 16, 2025 | AWARD | 43,860 | — | — | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Jul 16, 2025 | AWARD | 136,842 | — | — | Form 4 |
| Burshtein Gregory | Chief of R&D | Jul 16, 2025 | AWARD | 200,000 | $2.28 | $456.0K | Form 4 |
| Burshtein Gregory | Chief of R&D | Jul 16, 2025 | AWARD | 26,316 | — | — | Form 4 |
| Yaacov-Garbeli Dana | Chief Financial Officer | Jul 16, 2025 | AWARD | 130,000 | $2.28 | $296.4K | Form 4 |
| Yaacov-Garbeli Dana | Chief Financial Officer | Jul 16, 2025 | AWARD | 26,316 | — | — | Form 4 |
| Gautam Leslie Velka | Chief Business Officer | May 8, 2025 | OTHER | 60,000 | $2.28 | $136.8K | Form 4 |
| Galitzer Hillel | Chief Operating Officer | Apr 28, 2025 | AWARD | 100,000 | $2.28 | $228.0K | Form 4 |
| Galitzer Hillel | Chief Operating Officer | Apr 28, 2025 | AWARD | 26,316 | — | — | Form 4 |
| LIEBERMAN GERALD M | director | Apr 1, 2025 | OPTION EX. | 23,952 | $1.00 | $24.0K | Form 4 |
| LIEBERMAN GERALD M | director | Apr 1, 2025 | OPTION EX. | 23,952 | $1.00 | $24.0K | Form 4 |
| Taitel Haya | director | Jan 15, 2025 | AWARD | 6,922 | — | — | Form 4 |
| Taitel Haya | director | Jan 15, 2025 | AWARD | 28,509 | $2.28 | $65.0K | Form 4 |
| OSTROV GERALD M | director | Jan 15, 2025 | AWARD | 8,038 | — | — | Form 4 |
| OSTROV GERALD M | director | Jan 15, 2025 | AWARD | 28,509 | $2.28 | $65.0K | Form 4 |
| Malca Yonatan | director | Jan 15, 2025 | AWARD | 8,216 | — | — | Form 4 |
| Malca Yonatan | director | Jan 15, 2025 | AWARD | 28,509 | $2.28 | $65.0K | Form 4 |
| LIEBERMAN GERALD M | director | Jan 15, 2025 | AWARD | 10,717 | — | — | Form 4 |
| LIEBERMAN GERALD M | director | Jan 15, 2025 | AWARD | 28,509 | $2.28 | $65.0K | Form 4 |
| Ellis Sean | director | Jan 15, 2025 | AWARD | 7,100 | — | — | Form 4 |
| Ellis Sean | director | Jan 15, 2025 | AWARD | 28,509 | $2.28 | $65.0K | Form 4 |
| Knoll Capital Management, LLC | 10 percent owner | Nov 14, 2024 | OTHER | 0 | — | — | Form 4 |
| Knoll Capital Management, LLC | 10 percent owner | Dec 22, 2023 | OTHER | 347,604 | — | — | Form 4 |
| Knoll Capital Management, LLC | 10 percent owner | Dec 22, 2023 | OTHER | 1,197,604 | $1.00 | $1.2M | Form 4 |
| Taitel Haya | director | Oct 2, 2024 | AWARD | 7,278 | — | — | Form 4 |
| OSTROV GERALD M | director | Oct 2, 2024 | AWARD | 8,452 | — | — | Form 4 |
| Malca Yonatan | director | Oct 2, 2024 | AWARD | 8,639 | — | — | Form 4 |
| LIEBERMAN GERALD M | director | Oct 2, 2024 | AWARD | 11,269 | — | — | Form 4 |
| Ellis Sean | director | Oct 2, 2024 | AWARD | 7,466 | — | — | Form 4 |
| OSTROV GERALD M | director | Aug 27, 2024 | AWARD | 20,446 | — | — | Form 4 |
| Taitel Haya | director | Aug 27, 2024 | AWARD | 15,335 | — | — | Form 4 |
| Ellis Sean | director | Aug 27, 2024 | AWARD | 18,061 | — | — | Form 4 |
| Malca Yonatan | director | Aug 27, 2024 | AWARD | 23,172 | — | — | Form 4 |
| LIEBERMAN GERALD M | director | Aug 27, 2024 | AWARD | 27,261 | — | — | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Jul 31, 2024 | AWARD | 500,000 | $1.99 | $995.0K | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Jul 31, 2024 | AWARD | 124,121 | — | — | Form 4 |
| Burshtein Gregory | Chief of R&D | May 28, 2024 | DISPOSED | 0 | — | — | Form 4 |
| Burshtein Gregory | Chief of R&D | May 28, 2024 | DISPOSED | 45,000 | $2.57 | $115.7K | Form 4 |
| Burshtein Gregory | Chief of R&D | May 28, 2024 | DISPOSED | 51,000 | $3.61 | $184.1K | Form 4 |
| Burshtein Gregory | Chief of R&D | May 28, 2024 | DISPOSED | 65,000 | $0.80 | $51.7K | Form 4 |
| Burshtein Gregory | Chief of R&D | May 28, 2024 | DISPOSED | 150,000 | $1.99 | $298.5K | Form 4 |
| Burshtein Gregory | Chief of R&D | May 28, 2024 | DISPOSED | 18,900 | $2.14 | $40.4K | Form 4 |
| Burshtein Gregory | Chief of R&D | May 28, 2024 | DISPOSED | 20,000 | $3.97 | $79.4K | Form 4 |
| Yaacov-Garbeli Dana | Chief Financial Officer | Apr 19, 2024 | AWARD | 130,000 | $1.99 | $258.7K | Form 4 |
| Yaacov-Garbeli Dana | Chief Financial Officer | Apr 19, 2024 | AWARD | 30,151 | — | — | Form 4 |
| Galitzer Hillel | Chief Operating Officer | Apr 19, 2024 | AWARD | 130,000 | $1.99 | $258.7K | Form 4 |
| Galitzer Hillel | Chief Operating Officer | Apr 19, 2024 | AWARD | 30,151 | — | — | Form 4 |
| Taitel Haya | director | Jan 12, 2024 | BUY | 9,500 | $0.99 | $9.4K | Form 4 |
| Taitel Haya | director | Jan 10, 2024 | BUY | 7,615 | $0.77 | $5.9K | Form 4 |
| Taitel Haya | director | Jan 1, 2024 | AWARD | 108,333 | $0.60 | $65.0K | Form 4 |
| GARCEAU ROGER | director | Jan 1, 2024 | AWARD | 108,333 | $0.60 | $65.0K | Form 4 |
| Malca Yonatan | director | Jan 1, 2024 | AWARD | 108,333 | $0.60 | $65.0K | Form 4 |
| OSTROV GERALD M | director | Jan 1, 2024 | AWARD | 108,333 | $0.60 | $65.0K | Form 4 |
| Mayron Ron | director | Jan 1, 2024 | AWARD | 108,333 | $0.60 | $65.0K | Form 4 |
| LIEBERMAN GERALD M | director | Jan 1, 2024 | AWARD | 108,333 | $0.60 | $65.0K | Form 4 |
| Ellis Sean | director | Jan 1, 2024 | AWARD | 108,333 | $0.60 | $65.0K | Form 4 |
| LIEBERMAN GERALD M | director | Dec 22, 2023 | BUY | 23,952 | $0.71 | $17.0K | Form 4 |
| LIEBERMAN GERALD M | director | Dec 22, 2023 | BUY | 23,952 | $1.00 | $24.0K | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Dec 22, 2023 | BUY | 23,952 | $0.71 | $17.0K | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Dec 22, 2023 | BUY | 23,952 | $1.00 | $24.0K | Form 4 |
| Taitel Haya | director | Sep 13, 2023 | AWARD | 33,368 | $0.81 | $27.0K | Form 4 |
| Toledano Miranda Jayne | director, officer: Chief Executive Officer | Sep 13, 2023 | AWARD | 350,000 | $0.80 | $278.3K | Form 4 |
| Taitel Haya | director | Aug 22, 2023 | BUY | 18,000 | $0.62 | $11.2K | Form 4 |
| Taitel Haya | director: | Jun 4, 2023 | OTHER | 0 | — | — | Form 4 |